Multidisciplinary care is essential for the optimal management of patients with liver cancer. Hepatologists play a central role in liver cancer care by assessing and managing underlying liver disease. Skills unique to hepatology include stratifying severity of liver disease, identifying and managing portal hypertension, understanding liver metabolism, and managing liver related toxicity of immune and other oncologic therapies.
The overall goal of this program is to introduce and discuss novel paradigms of HCC management and the integration of hepatology into the systemic therapy of HCC. In the first session, we will explore European and Asian models of care delivery, assess the current state of systemic therapies, consider real-world application of clinical trials data to complex cases, and understand how to anticipate and manage side effects of systemic therapy.
Presentations
8:00 AM - 8:03 AM
Nov
18
2024
San Diego, CA
Introduction
Tamar Taddei, MD, MD, FAASLD, Moderator
8:03 AM - 8:18 AM
Nov
18
2024
San Diego, CA
Current landscape of systemic treatments, incl. patient monitoring and adverse events
Mark Yarchoan, Presenter
8:18 AM - 8:33 AM
Nov
18
2024
San Diego, CA
Systemic Therapy in a Multidisciplinary Management Setting – The Role of a Hepatologist
Tim F Greten, Presenter
8:33 AM - 8:48 AM
Nov
18
2024
San Diego, CA
Liver Dysfunction following Systemic Therapy for HCC
Anjana Pillai, MD, FAASLD, Presenter
8:48 AM - 8:58 AM
Nov
18
2024
San Diego, CA
Alternate Care Models - China
Andrew X Zhu, MD, PhD, Presenter
8:58 AM - 9:08 AM
Nov
18
2024
San Diego, CA
Alternate Care Models - Japan
Masatoshi MK Kudo, MD, PhD, Presenter
9:08 AM - 9:18 AM
Nov
18
2024
San Diego, CA
Alternate Care Models - Latin America
Federico Piñero, MD, Msc, PhD, Presenter
9:18 AM - 9:30 AM
Nov
18
2024
San Diego, CA
Q&A/Panel Discussion - All Presenters
Tamar Taddei, MD, MD, FAASLD, Moderator
Objectives
Learn about the global diversity of HCC care delivery practices
Describe the currently available systemic therapies for treating patients with HCC and real-world approaches to complex cases
Identify and manage immune related adverse effects of immune therapies